Sheila S. Teves
Molecular Biology · 2013
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 6 citations into it
- Oncology — 6 citations into it
Whom Sheila S. Teves trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Sheila S. Teves's perspective
Ordered by how strongly the researchers Sheila S. Teves trusts endorse each paper. Same corpus, a different order for every researcher.
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity (Nature Medicine)
- Doxorubicin pathways: pharmacodynamics and adverse effects (Pharmacogenetics & Genomics)
- Targeting DNA topoisomerase II in cancer chemotherapy (Nature Reviews. Cancer)
- Doxorubicin: the good, the bad and the ugly effect. (Current Medicinal Chemistry)
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron (Pharmacological Reports)
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation (Nature)
- BioPAX – A community standard for pathway data sharing (Nature Biotechnology)
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines (Clinical pharmacology and therapy)
- Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text
- DrugBank: a comprehensive resource for in silico drug discovery and exploration
Their papers
- Doxorubicin, DNA torsion, and chromatin dynamics (2013) — 686 citations